[{"address1": "830 Winter Street", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "781 999 0232", "website": "https://www.q32bio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti\u0096interleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb \u0096 CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.", "fullTimeEmployees": 42, "companyOfficers": [{"maxAge": 1, "name": "Dr. Shelia M. Violette Ph.D.", "age": 63, "title": "Co-founder, Chief Scientific Officer & President of Research", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 619930, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Saul W. Fink Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Appugliese J.D.", "title": "Senior VP & Head of People", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maria  Marzilli M.P.H.", "title": "Executive Vice President of Corporate Strategy & Program Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.57, "open": 1.61, "dayLow": 1.4902, "dayHigh": 1.63, "regularMarketPreviousClose": 1.57, "regularMarketOpen": 1.61, "regularMarketDayLow": 1.4902, "regularMarketDayHigh": 1.63, "payoutRatio": 0.0, "forwardPE": -0.30037314, "volume": 85139, "regularMarketVolume": 85139, "averageVolume": 217052, "averageVolume10days": 251420, "averageDailyVolume10Day": 251420, "bid": 1.56, "ask": 1.66, "bidSize": 1, "askSize": 1, "marketCap": 19638136, "fiftyTwoWeekLow": 1.38, "fiftyTwoWeekHigh": 53.79, "fiftyDayAverage": 1.8927, "twoHundredDayAverage": 21.291574, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -39913744, "profitMargins": 0.0, "floatShares": 5426353, "sharesOutstanding": 12197600, "sharesShort": 868525, "sharesShortPriorMonth": 1008620, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0577, "heldPercentInsiders": 0.065689996, "heldPercentInstitutions": 0.79329, "shortRatio": 4.11, "impliedSharesOutstanding": 12197600, "bookValue": 0.465, "priceToBook": 3.4623656, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -47733000, "trailingEps": -6.58, "forwardEps": -5.36, "lastSplitFactor": "1:18", "lastSplitDate": 1711411200, "enterpriseToEbitda": 0.608, "52WeekChange": -0.94141793, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 1.61, "targetHighPrice": 20.0, "targetLowPrice": 6.0, "targetMeanPrice": 13.66667, "targetMedianPrice": 15.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 77965000, "totalCashPerShare": 6.392, "ebitda": -65615000, "totalDebt": 18901000, "quickRatio": 4.769, "currentRatio": 4.973, "debtToEquity": 333.057, "returnOnAssets": -0.59278, "grossProfits": -48143000, "freeCashflow": -37946752, "operatingCashflow": -67715000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "QTTB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "REGULAR", "shortName": "Q32 Bio Inc.", "longName": "Q32 Bio Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1522243800000, "regularMarketChange": 0.03999996, "regularMarketDayRange": "1.4902 - 1.63", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 217052, "fiftyTwoWeekLowChange": 0.23000002, "fiftyTwoWeekLowChangePercent": 0.16666669, "fiftyTwoWeekRange": "1.38 - 53.79", "fiftyTwoWeekHighChange": -52.18, "fiftyTwoWeekHighChangePercent": -0.97006875, "fiftyTwoWeekChangePercent": -94.14179, "earningsTimestamp": 1746701947, "earningsTimestampStart": 1746701947, "earningsTimestampEnd": 1746701947, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -6.58, "epsForward": -5.36, "fiftyDayAverageChange": -0.28269994, "fiftyDayAverageChangePercent": -0.14936331, "twoHundredDayAverageChange": -19.681574, "twoHundredDayAverageChangePercent": -0.9243832, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "corporateActions": [], "regularMarketTime": 1746724419, "exchange": "NCM", "messageBoardId": "finmb_669405676", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.547768, "regularMarketPrice": 1.61, "displayName": "Q32 Bio", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]